These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 28834972)

  • 1. [Healthcare Research into Anti-VEGF Therapy: Selection and Methodological Precautions].
    Ziemssen F; Stahl A; Dimopoulos S
    Klin Monbl Augenheilkd; 2017 Dec; 234(12):1483-1492. PubMed ID: 28834972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Observational study designs for comparative effectiveness research: an alternative approach to close evidence gaps in head-and-neck cancer.
    Goulart BH; Ramsey SD; Parvathaneni U
    Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):106-14. PubMed ID: 24331656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema.
    Parravano M; Menchini F; Virgili G
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007419. PubMed ID: 19821414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demographics of patients receiving Intravitreal anti-VEGF treatment in real-world practice: healthcare research data versus randomized controlled trials.
    Ziemssen F; Feltgen N; Holz FG; Guthoff R; Ringwald A; Bertelmann T; Wiedon A; Korb C;
    BMC Ophthalmol; 2017 Jan; 17(1):7. PubMed ID: 28103831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal Bevacizumab and Cardiovascular Risk in Patients with Age-Related Macular Degeneration: Systematic Review and Meta-Analysis of Randomized Controlled Trials and Observational Studies.
    Mikačić I; Bosnar D
    Drug Saf; 2016 Jun; 39(6):517-41. PubMed ID: 26951234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complementing the randomized controlled trial evidence base. Evolution not revolution.
    Price D; Bateman ED; Chisholm A; Papadopoulos NG; Bosnic-Anticevich S; Pizzichini E; Hillyer EV; Buist AS
    Ann Am Thorac Soc; 2014 Feb; 11 Suppl 2():S92-8. PubMed ID: 24559027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [What can anti-VEGF therapy achieve in clinical routine? : Effectiveness of anti-VEGF therapy in patients with macular diseases in clinical routine on 1492 eyes in Austria].
    Wiesinger K; Reinelt P; Ennemoser A; Edelmayr M; Schönherr U
    Ophthalmologe; 2017 Jul; 114(7):639-645. PubMed ID: 27815675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomisation to protect against selection bias in healthcare trials.
    Kunz R; Vist G; Oxman AD
    Cochrane Database Syst Rev; 2007 Apr; (2):MR000012. PubMed ID: 17443633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-world outcomes in patients with neovascular age-related macular degeneration treated with intravitreal vascular endothelial growth factor inhibitors.
    Mehta H; Tufail A; Daien V; Lee AY; Nguyen V; Ozturk M; Barthelmes D; Gillies MC
    Prog Retin Eye Res; 2018 Jul; 65():127-146. PubMed ID: 29305324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optical Coherence Tomography Monitoring Strategies for A-VEGF-Treated Age-Related Macular Degeneration: An Evidence-Based Analysis.
    Pron G
    Ont Health Technol Assess Ser; 2014; 14(10):1-64. PubMed ID: 26316918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Series: Pragmatic trials and real world evidence: Paper 1. Introduction.
    Zuidgeest MGP; Goetz I; Groenwold RHH; Irving E; van Thiel GJMW; Grobbee DE;
    J Clin Epidemiol; 2017 Aug; 88():7-13. PubMed ID: 28549929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using routine data to complement and enhance the results of randomised controlled trials.
    Lewsey JD; Leyland AH; Murray GD; Boddy FA
    Health Technol Assess; 2000; 4(22):1-55. PubMed ID: 11074392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular events and bleeding risk associated with intravitreal antivascular endothelial growth factor monoclonal antibodies: systematic review and meta-analysis.
    Thulliez M; Angoulvant D; Le Lez ML; Jonville-Bera AP; Pisella PJ; Gueyffier F; Bejan-Angoulvant T
    JAMA Ophthalmol; 2014 Nov; 132(11):1317-26. PubMed ID: 25058694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review of the efficacy and safety outcomes of anti-VEGF agents used for treating neovascular age-related macular degeneration: comparison of ranibizumab and bevacizumab.
    Mitchell P
    Curr Med Res Opin; 2011 Jul; 27(7):1465-75. PubMed ID: 21623685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety implications of vascular endothelial growth factor blockade for subjects receiving intravitreal anti-vascular endothelial growth factor therapies.
    Csaky K; Do DV
    Am J Ophthalmol; 2009 Nov; 148(5):647-56. PubMed ID: 19712924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Phase 1 Study of Intravitreous E10030 in Combination with Ranibizumab in Neovascular Age-Related Macular Degeneration.
    Jaffe GJ; Eliott D; Wells JA; Prenner JL; Papp A; Patel S
    Ophthalmology; 2016 Jan; 123(1):78-85. PubMed ID: 26499921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review of comparisons of effect sizes derived from randomised and non-randomised studies.
    MacLehose RR; Reeves BC; Harvey IM; Sheldon TA; Russell IT; Black AM
    Health Technol Assess; 2000; 4(34):1-154. PubMed ID: 11134917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethical pitfalls in neonatal comparative effectiveness trials.
    Modi N
    Neonatology; 2014; 105(4):350-1. PubMed ID: 24931328
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.